DK471386A - Farmaceutisk komposition til behandling af leukopeni - Google Patents

Farmaceutisk komposition til behandling af leukopeni Download PDF

Info

Publication number
DK471386A
DK471386A DK471386A DK471386A DK471386A DK 471386 A DK471386 A DK 471386A DK 471386 A DK471386 A DK 471386A DK 471386 A DK471386 A DK 471386A DK 471386 A DK471386 A DK 471386A
Authority
DK
Denmark
Prior art keywords
human
csf
leukopeni
treatment
pharmaceutical composition
Prior art date
Application number
DK471386A
Other languages
English (en)
Other versions
DK172204B1 (da
DK471386D0 (da
Inventor
Masahiko Tamura
Hitoshi Nomura
Kunihiro Hattori
Masayoshi Ono
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26462024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK471386(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DK471386D0 publication Critical patent/DK471386D0/da
Publication of DK471386A publication Critical patent/DK471386A/da
Application granted granted Critical
Publication of DK172204B1 publication Critical patent/DK172204B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK471386A 1985-10-04 1986-10-02 Farmaceutisk komposition indeholdende human granulocytkolonistimulerende faktor til behandling af leukopeni DK172204B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP22045085 1985-10-04
JP22045085 1985-10-04
JP12566086 1986-06-02
JP61125660A JPH0618778B2 (ja) 1985-10-04 1986-06-02 白血球減少症治療剤

Publications (3)

Publication Number Publication Date
DK471386D0 DK471386D0 (da) 1986-10-02
DK471386A true DK471386A (da) 1987-04-05
DK172204B1 DK172204B1 (da) 1998-01-05

Family

ID=26462024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK471386A DK172204B1 (da) 1985-10-04 1986-10-02 Farmaceutisk komposition indeholdende human granulocytkolonistimulerende faktor til behandling af leukopeni

Country Status (11)

Country Link
EP (1) EP0217404B2 (da)
JP (1) JPH0618778B2 (da)
KR (1) KR960000394B1 (da)
AT (1) ATE71662T1 (da)
AU (1) AU596997C (da)
DE (1) DE3683430D1 (da)
DK (1) DK172204B1 (da)
ES (1) ES2055684T5 (da)
FI (1) FI863971A7 (da)
HK (1) HK65693A (da)
NO (1) NO863918L (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921837A (en) * 1985-11-27 1990-05-01 Genetics Institute Inc. Treatment of AIDS-type disease
JPH0618779B2 (ja) * 1986-01-22 1994-03-16 中外製薬株式会社 造血機能回復促進剤
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
CA1329119C (en) * 1988-03-29 1994-05-03 Milton David Goldenberg Cytotoxic therapy
ATE89737T1 (de) * 1989-01-30 1993-06-15 Schering Corp Behandlung von leukozytstoerungen mit gm-csf.
WO1992011022A1 (fr) * 1990-12-25 1992-07-09 Kyowa Hakko Kogyo Co., Ltd. Preparation pharmaceutique destinee a une administration par voie nasale
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5686578A (en) 1994-08-05 1997-11-11 Immunomedics, Inc. Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
EP2206720A1 (en) 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albumin fusion proteins
US8435939B2 (en) 2000-09-05 2013-05-07 Biokine Therapeutics Ltd. Polypeptide anti-HIV agent containing the same
EP2261250B1 (en) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin fusion proteins
SI21273A (sl) * 2002-07-31 2004-02-29 LEK farmacevtska dru�ba d.d. Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
WO2004020462A1 (ja) 2002-08-27 2004-03-11 Fujii, Nobutaka Ｃｘｃｒ４拮抗薬およびその用途
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
KR100638453B1 (ko) * 2004-11-19 2006-10-24 씨제이 주식회사 포장용 박스 및 포장용 박스 접는방법
CA2673719C (en) 2006-12-21 2018-07-24 Biokine Therapeutics Ltd. T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery
US9155780B2 (en) 2009-02-11 2015-10-13 Yeda Research And Development Co. Ltd. Short beta-defensin-derived peptides
US9427456B2 (en) 2009-06-14 2016-08-30 Biokine Therapeutics Ltd. Peptide therapy for increasing platelet levels
US9439942B2 (en) 2012-04-24 2016-09-13 Biokine Therapeutics Ltd. Peptides and use thereof in the treatment of large cell lung cancer
IL274572B2 (en) 2015-07-16 2024-01-01 Biolinerx Ltd Compositions and methods for treating cancer
CN109310733A (zh) 2016-02-23 2019-02-05 百欧林纳克斯有限公司 治疗急性骨髓性白血病的方法
CN112175906B (zh) * 2019-07-05 2023-09-29 中国科学院生物物理研究所 胸腺嘧啶核苷诱导成纤维细胞转分化在中性粒细胞减少症治疗中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030295B2 (ja) * 1977-03-29 1985-07-16 森永乳業株式会社 白血球減少症治療剤の製造法
SE451844B (sv) * 1978-03-20 1987-11-02 Morinaga Milk Industry Co Ltd Glykoprotein, forfarande for framstellning derav samt terapeutiskt medel innehallande nemnda glykoprotein
JPS6030291B2 (ja) * 1978-03-20 1985-07-16 森永乳業株式会社 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
JPS5618591A (en) * 1979-07-20 1981-02-21 Morinaga Milk Ind Co Ltd Production of substance capable of differentiation and multiplication of stem cells of human granulocyte
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
JPS61227526A (ja) * 1984-07-25 1986-10-09 Chugai Pharmaceut Co Ltd 新規なコロニー刺激因子
JPS6181781A (ja) * 1984-09-28 1986-04-25 Morinaga Milk Ind Co Ltd 人顆粒球系前駆細胞の分化・増殖因子産生細胞および人顆粒球系前駆細胞の分化・増殖因子の製造法
IL77080A (en) * 1984-11-20 1998-02-08 Schering Biotech Corp Polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity, vectors and transformed cells for their production and pharmaceutical compositions comprising them
AU590543B2 (en) * 1985-02-05 1989-11-09 Albert Einstein College Of Medicine Of Yeshiva University Purification of native colony stimulating factor-1
EP0215126B1 (en) * 1985-02-08 1991-07-31 Chugai Seiyaku Kabushiki Kaisha Human granulocyte colony stimulating factor
JPH0615477B2 (ja) * 1985-02-08 1994-03-02 中外製薬株式会社 感染防禦剤
JPS63500636A (ja) * 1985-08-23 1988-03-10 麒麟麦酒株式会社 多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
DE3681551D1 (de) * 1985-09-30 1991-10-24 Chugai Pharmaceutical Co Ltd Menschlicher granulozyten-colony stimulierender faktor.
JPS6444200A (en) * 1987-08-12 1989-02-16 Kenji Hoshino Stereophonic sound field recording and reproducing system
JPH0615477A (ja) * 1992-07-02 1994-01-25 Tanaka Kikinzoku Kogyo Kk Ａｇろう

Also Published As

Publication number Publication date
DK172204B1 (da) 1998-01-05
EP0217404B1 (en) 1992-01-15
FI863971L (fi) 1987-04-05
FI863971A7 (fi) 1987-04-05
EP0217404B2 (en) 1999-01-07
HK65693A (en) 1993-07-16
AU596997C (en) 1993-01-21
ES2055684T5 (es) 1999-06-16
EP0217404A2 (en) 1987-04-08
EP0217404A3 (en) 1988-07-13
DK471386D0 (da) 1986-10-02
JPH0618778B2 (ja) 1994-03-16
KR960000394B1 (ko) 1996-01-06
FI863971A0 (fi) 1986-10-01
JPS62174026A (ja) 1987-07-30
ES2055684T3 (es) 1994-09-01
AU6312186A (en) 1987-04-09
AU596997B2 (en) 1990-05-24
NO863918L (no) 1987-04-06
DE3683430D1 (de) 1992-02-27
NO863918D0 (no) 1986-10-02
ATE71662T1 (de) 1992-02-15
KR870003792A (ko) 1987-05-04

Similar Documents

Publication Publication Date Title
DK471386D0 (da) Farmaceutisk komposition til behandling af leukopeni
DE3680613D1 (de) Menschlicher granuloxcyt-kolonie-stimulierungsfaktor.
LV12642A (lv) G csf analog compositions and methods
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
HUT38125A (en) Process for preparing lymphokines /cytotoxic factors/ and pharmaceutical compositions containing such active substance
DK0559884T4 (da) Rekombinante virusvektorer til ekspression i muskelceller
EP0230980A3 (en) Pharmaceutical agent for promoting the recovery of hemopoietic capacity
DE3681551D1 (de) Menschlicher granulozyten-colony stimulierender faktor.
EP0231819A3 (en) Pharmaceutical agent for the treatment of myelogenous leukemia
DE69007744D1 (de) Verwendung von Interleukin 2 zur Behandlung von Leukämien.
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
DK12990A (da) Human granulocyt-makrofag-kolonistimulerende faktor og muteiner heraf
ATE100717T1 (de) Intralaesionale behandlung von basalzellenkarzinoma mittels rekombinanten humanen alpha-interferons.
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
ATE241698T1 (de) Hst-2 mutein, dafür kodierende dns und herstellung

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired